Kestra Advisory Services’s Palisade Bio PALI Stock Holding History

Kestra Advisory Services’s Portfolio PALI Stock Details PALI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$26.1K	Buy	+12,504	New	+$24.6K	﹤0.01%	3233

Other funds holding PALI

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

SAM

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

PFSRSONJ

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

TCWM

Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return

STRS Ohio Columbus, Ohio $26.7B AUM 43.32% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

NAM

NorthCrest Asset Manangement Plymouth, Minnesota $3.89B AUM 40.33% 1-Year Est. Return

Kestra Advisory Services's PALI Position: Q2 2026 in Review

Kestra Advisory Services opened a new position in Palisade Bio (PALI) in Q2 2026: 12,504 shares worth $26.1K. The stake represents ﹤0.01% of the portfolio and ranks #3233 among its holdings.

15 funds tracked by Wall St. Rank hold PALI as of Q2 2026.

Kestra Advisory Services held 12,504 shares of Palisade Bio worth $26.1K as of Q2 2026.
Palisade Bio was a new Kestra Advisory Services position in Q2 2026.
Palisade Bio made up ﹤0.01% of Kestra Advisory Services's portfolio in Q2 2026, its #3233 holding.
15 funds tracked by Wall St. Rank held Palisade Bio as of Q2 2026.

Based on Kestra Advisory Services's 13F filing for Q2 2026, filed 28 Jul 2026.